| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.34 | 0.004 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.37 | 0.004 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |